The largest database of trusted experimental protocols

Ma5 29698

Manufactured by Thermo Fisher Scientific

The MA5-29698 is a laboratory equipment product manufactured by Thermo Fisher Scientific. It is designed for specific laboratory functions, but a detailed description cannot be provided while maintaining an unbiased and strictly factual approach. Additional information about the intended use or features of this product is not available.

Automatically generated - may contain errors

2 protocols using ma5 29698

1

Xenograft Model of Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Indiana University Animal Care and Use Committee approved the use of animals in this study and all procedures were performed as per NIH guidelines. Transformed cells with 50% basement membrane matrix (BME) type 3 (3632-005-02, Trevigen) (total 100 µL volume) were implanted into the mammary fat pad of 5–6-week-old female NSG (NOD/SCID/IL2Rgnull) mice. A 60-days slow release 17β-estradiol (0.72 mg) pellet (SE-121, Innovative Research of America) was implanted at the time of mammary fat pad injection. Tumor growth was measured weekly and tumor volume was calculated using the formula- sagittal dimension (mm) × [cross dimension (mm)]2/243 (link). The maximal tumor burden permitted by the Indiana University Animal Care and Use Committee is 2 cm × 2 cm. The maximal tumor burden was never exceeded during this study. After 2–4 months, tumors and lungs were collected and processed for hematoxylin and eosin (H&E), ERα, GATA3, FOXA1, EpCAM (MA5-29698, Invitrogen,1:500), CK5/6 (IR 780, Dako, Ready-to-use), CK8 (35bH11, N1560, Dako, 10 µg/ml), CK14 (LL002, ab7800, Abcam, 1 µg/ml), and CK19 (IR 615, Dako, Ready-to-use) staining43 (link).
+ Open protocol
+ Expand
2

Tumor Growth Dynamics and Marker Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor cells (10,000, 50,000, 100,000, 1 × 106, or 5 × 106, total 100-μl volume) processed at 3% O2 and 21% O2 were implanted into the fifth inguinal mammary fat pad of each 6- to 8-week-old syngeneic FVB/N female mice without expanding in culture. Tumor growth was measured weekly, and tumor volume was calculated as described previously (55 (link)). Tumor tissues were harvested and divided into two fractions at their respective 3% O2 or ambient air. One fraction was collected for immunohistochemistry, and the other fraction was dissociated using a 10% collagenase/hyaluronidase enzyme mixture and processed at their respective 3% O2 or ambient air, and cells were either processed immediately for CSC marker profiles, reinjected into animals, or cultured at 5% O2 and 21% O2.
H&E, LGR5, TSPAN8, EpCAM, CK19, and CK14 immunostaining was performed at the CLIA (clinical laboratory improvement amendments)-certified Indiana University Health Pathology Laboratory, and the whole-slide digital imaging system of Aperio (ScanScope CS) was used for imaging according to a protocol described previously (55 (link)). The following antibodies were used: LGR5 (ab75732, Abcam), TSPAN8 (PA5-75311, Invitrogen), EpCAM (MA5-29698, Invitrogen), CK19 (IR 615, Dako), and CK14 (LL002, ab7800, Abcam).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!